These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 34906501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TAB2 variants cause cardiovascular heart disease, connective tissue disorder, and developmental delay.
    Hanson J, Brezavar D, Hughes S, Amudhavalli S, Fleming E, Zhou D, Alaimo JT, Bonnen PE.
    Clin Genet; 2022 Feb; 101(2):214-220. PubMed ID: 34741306
    [Abstract] [Full Text] [Related]

  • 7. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
    Morlon A, Munnich A, Smahi A.
    Hum Mol Genet; 2005 Dec 01; 14(23):3751-7. PubMed ID: 16251197
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.
    Prickett TD, Ninomiya-Tsuji J, Broglie P, Muratore-Schroeder TL, Shabanowitz J, Hunt DF, Brautigan DL.
    J Biol Chem; 2008 Jul 11; 283(28):19245-54. PubMed ID: 18456659
    [Abstract] [Full Text] [Related]

  • 10. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.
    Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, Matsumoto K.
    EMBO J; 2003 Dec 01; 22(23):6277-88. PubMed ID: 14633987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
    Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, Sakurai N.
    Mol Cell Biol; 2002 Feb 01; 22(4):992-1000. PubMed ID: 11809792
    [Abstract] [Full Text] [Related]

  • 16. TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility.
    Engwerda A, Leenders EKSM, Frentz B, Terhal PA, Löhner K, de Vries BBA, Dijkhuizen T, Vos YJ, Rinne T, van den Berg MP, Roofthooft MTR, Deelen P, van Ravenswaaij-Arts CMA, Kerstjens-Frederikse WS.
    Eur J Hum Genet; 2021 Nov 01; 29(11):1669-1676. PubMed ID: 34456334
    [Abstract] [Full Text] [Related]

  • 17. 6q25.1 (TAB2) microdeletion is a risk factor for hypoplastic left heart: a case report that expands the phenotype.
    Cheng A, Neufeld-Kaiser W, Byers PH, Liu YJ.
    BMC Cardiovasc Disord; 2020 Mar 17; 20(1):137. PubMed ID: 32183715
    [Abstract] [Full Text] [Related]

  • 18. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
    Moon G, Kim J, Min Y, Wi SM, Shim JH, Chun E, Lee KY.
    Cell Signal; 2015 Dec 17; 27(12):2524-33. PubMed ID: 26432169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.